From the International Association for the Study of Pain World Congress #WC2024 👇
This week, I am in Amsterdam, attending the International Association for the Study of Pain World Congress on Pain. So much of the power of science and clinical development is realized through community—through the ways we share research, come together around tough challenges, and work together to tackle disease. It is timely and richly motivating to be here within weeks of my joining the Latigo Biotherapeutics, Inc. team as CEO, a company dedicated to addressing pain with effective non-opioid solutions. If you can join us, on Friday 9 August, our SVP Discovery, Bryan Moyer, will present a poster about the research he and his co-authors led in finding a path to silence pain-signaling neurons by blocking a sodium channel called NaV 1.8. Use the link below for details. Over the next few days, I look forward to meeting attendees and representing our company mission to bring effective non-opioid therapeutic options to patients. Nima https://lnkd.in/gMjA4fR7 #IASP2024 #IASPCongress #PainResearch #NonOpioidMedicine
